(R)-3-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propylcarbamoyl]-dodecanoic acid tert-butyl ester | 343251-08-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-3-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propylcarbamoyl]-dodecanoic acid tert-butyl ester
• CAS: 343251-08-1
• 化学式: C₃₁H₅₂N₂O₄
• 分子量: 516.765
• InChiKey: BJXDTNZOTGBXDB-DFZDUAMZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.88
• 重原子数：
  37.0
• 可旋转键数：
  15.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  84.5
• 氢给体数：
  2.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  (R)-3-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propylcarbamoyl]-dodecanoic acid tert-butyl ester 在 bis(triphenylphosphine) palladium (Il) acetate 盐酸 、 N-羟基-7-氮杂苯并三氮唑 、 ammonium formate 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 20.0h， 生成 (R)-N¹-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propyl]-N⁴-hydroxy-2-nonyl-succinamide
  参考文献：
  名称：

  Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (Stromelysin-1)

  摘要：

  Structure-activity relationships are described for a series of succinyl hydroxamic acids 4a-o as potent and selective inhibitors of matrix metalloprotease-3 (stromelysin-1). Optimisation of P1' and P3' groups gave compound 4j (MMP-3 IC50 = 5.9nM) which was >140-fold less potent against MMP-1 (IC50 = 51,000nM), MMP-2 (IC50=1790nM), MMP-9 (IC50 = 840 nM) and MMP-14 (IC50 = 1900 nM). (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00720-4
• 作为产物：
  描述：

  R-2-nonyl-succinic acid 4-t-butyl ester 、 (2S)-2-Amino-3,3-dimethyl-N-[(1R)-1-phenylethyl]butanamide 在 N-甲基吗啉 、 N-羟基-7-氮杂苯并三氮唑 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 18.0h， 生成 (R)-3-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propylcarbamoyl]-dodecanoic acid tert-butyl ester
  参考文献：
  名称：

  Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (Stromelysin-1)

  摘要：

  Structure-activity relationships are described for a series of succinyl hydroxamic acids 4a-o as potent and selective inhibitors of matrix metalloprotease-3 (stromelysin-1). Optimisation of P1' and P3' groups gave compound 4j (MMP-3 IC50 = 5.9nM) which was >140-fold less potent against MMP-1 (IC50 = 51,000nM), MMP-2 (IC50=1790nM), MMP-9 (IC50 = 840 nM) and MMP-14 (IC50 = 1900 nM). (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00720-4